Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature
2010
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
2013
Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years
2012
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
2009
Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients
2005
Impact of a Weight Management Program on Health-Related Quality of Life in Overweight Adults With Type 2 Diabetes
2009
Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects
2001
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
Long-Term Impaired Quality of Life in Cushing’s Syndrome despite Initial Improvement after Surgical Remission
2006
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Sex Hormones and Sexual Function in Obese Men Losing Weight
2003
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
1995 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Cushing’s Syndrome: Adrenalectomy and Long-Term Results
2004
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
2013 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Stereotactic radiosurgery for Cushing disease: a review
2007
Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus
1992
Mortality in Cushing's syndrome: A systematic review and meta-analysis
2011
The metabolic syndrome
2010 Standout
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
2001
Cushing's syndrome
2015 Standout
Bariatric Surgery
2004 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study
2000 Standout
An independent association between obstructive sleep apnoea and coronary artery disease
1999
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
2008
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study
2001
Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins
1991
Diabetic dyslipidaemia: from basic research to clinical practice*
2003
CLINICAL REVIEW ARTICLE: Weight loss as a treatment for obstructive sleep apnoea
2000
The metabolic syndrome
2005 Standout
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
1999 Standout
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire
2008
Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
1999
Prevention of Heart Failure
2008
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Type 2 diabetes
2017 Standout
Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women
2009 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Type 1 diabetes
2013 Standout
Polycystic Ovary Syndrome
2005 Standout
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
2003
Body Fat Distribution and Sleep Apnea Severity in Women
1995
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome
2002
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Recurrence of Sleep Apnea Without Concomitant Weight Increase 7.5 Years After Weight Reduction Surgery
1994
The Association of Hypertension and Secondary Cardiovascular Disease With Sleep-Disordered Breathing
2003
Mortality and morbidity in Cushing’s syndrome in New Zealand
2011
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Cushing's syndrome
2006 Standout
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
2005 Standout
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects
2006
Atherosclerosis
2001 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
The effect of a very low‐calorie diet‐induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome
1998
Prediabetes: a high-risk state for diabetes development
2012 Standout
Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study
2007
Longitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
CLINICAL REVIEW ARTICLE: Epidemiology of sleep-related obstructive breathing
2000
The Prevalence of Obstructive Sleep Apnea in Hypertensives
1998
Epidemiology of Obstructive Sleep Apnea
2002 Standout
Respiratory Disturbance Index
2000
Sleep-disordered Breathing and Insulin Resistance in Middle-aged and Overweight Men
2002
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
Effects of the Luteinizing Hormone-Releasing Hormone Agonist Leuprolide on Lipoproteins, Fibrinogen and Plasminogen Activator Inhibitor in Patients with Benign Prostatic Hyperplasia
1995
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Trends in Obesity Among Adults in the United States, 2005 to 2014
2016 Standout
Pravastatin and the Development of Diabetes Mellitus
2001
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients
2005
Dietary influences on serum lipids and lipoproteins.
1990
Pharmacological and surgical treatment of obesity.
2004
Specificity of First-Line Tests for the Diagnosis of Cushing’s Syndrome: Assessment in a Large Series
2007
Comparison of Insulin With or Without Continuation of Oral Hypoglycemic Agents in the Treatment of Secondary Failure in NIDDM Patients
1995
Metabolic and health complications of obesity.
1990
Free Fatty Acids Are Independently Associated with All-Cause and Cardiovascular Mortality in Subjects with Coronary Artery Disease
2006
HYPERTENSION, CARDIAC ARRHYTHMIAS, MYOCARDIAL INFARCTION, AND STROKE IN RELATION TO OBSTRUCTIVE SLEEP APNEA
1992
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome
2007
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
2013
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol as Screening Tests for Cushing’s Syndrome
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Epidemiology of Cushing’s Syndrome
2010
Type 1 and Type 2 Diabetes
2005
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
2000
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
2005 Standout
The effect of weight loss on health‐related quality of life: systematic review and meta‐analysis of randomized trials
2013
Works of T Sane being referenced
Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes
2005
Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification—a 2-y follow-up study
2003
Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification: a 2-y follow-up study
2003
One‐year response to evening insulin therapy in non‐insulin‐dependent diabetes
1992
Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype–phenotype correlation
2007
The survival and well‐being of patients treated for Cushing’s syndrome
1999
Obstructive sleep apnoea syndrome in morbidly obese patients
1991
LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes
1995
Health-related quality of life in WHO Class II–III obese men losing weight with very-low-energy diet and behaviour modification: a randomised clinical trial
2002
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4
1998
Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia
1995
Effects of Orchiectomy and Polyestradiol Phosphate Therapy onSerum Lipoprotein Lipids and Glucose Tolerance inProstatic Cancer Patients
1990
Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients
1995
Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
1998
Hyponatremia after transsphenoidal surgery for pituitary tumors.
1994
Postmarathon paradox: insulin resistance in the face of glycogen depletion
1996
Midnight serum cortisol: comparison of healthy volunteers and hospitalized patients with Cushing's syndrome.
2002
Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen
1985
Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Evidence for genetic control of triglyceride removal.
1988